Tag: PLD1

Bispecific antibodies (BsAbs) have confirmed highly efficient T cell recruiters for cancer immunotherapy by virtue of one tumor antigen-reactive single chain variable fragment (scFv) and another that binds CD3. induce dimerization was assayed by dynamic light scattering and size exclusion chromatography (observe Table 1 and Fig. S1). GD2xCD3 BsAb (MW 54?kDa) had a diameter of…